The 2019 European Society of Cardiology guidelines on the diagnosis and treatment of
acute pulmonary embolism (PE), developed with the European Respiratory Society, provide …

We read with great interest the paper by Yamashita and colleagues, in which they show that
patients with high-risk pulmonary embolism (PE) at initial diagnosis more frequently …

Background Improved prediction of the risk of major bleeding in patients with acute
pulmonary embolism (PE) receiving systemic thrombolysis is crucial to guide the choice of …

Methods We conducted the literature search in MEDLINE, EMBASE, the Cochrane Register
of Controlled Trials, Web of Knowledge, and CINAHL databases, until July 20, 2014. We …

Contemporary outcomes in patients hospitalized with pulmonary embolism: what can we learn
from observational data? Page 1 Contemporary outcomes in patients hospitalized with …

I eagerly read the recent article by Becattini et al.[1] entitled “Acute pulmonary embolism:
mortality prediction by the 2014 European Society of Cardiology risk stratification model” …

Background: Pulmonary emboli (PE) represents an extended spectrum of diseases. 10% of
submassive PE progress to massive PE, and while overall mortality is around 5%, it can …

Introduction Intermediate-high risk pulmonary embolism (IHR-PE) has a poor prognosis, but
is under-represented in trials of direct oral anticoagulants (DOACs) in venous …

Pulmonary embolism (PE) is the third most frequent acute cardiovascular syndrome. Annual
PE incidence and PE-related mortality rates rise exponentially with age, and consequently …

Background This systematic review addresses the controversy over the decision to
anticoagulate patients with subsegmental pulmonary embolism (SSPE). Methods We …